Status
Conditions
Treatments
About
to investigate the effect of the human incretin hormone GLP-1 on mesenteric blood flow and cardiac parameters
Full description
to investigate the effect of the human incretin hormone GLP-1 on mesenteric blood flow and cardiac parameters, in healthy subjects, 4 arms, task force monitor
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
8 participants in 4 patient groups, including a placebo group
Loading...
Central trial contact
Lasse Bremholm, MD, ph.d.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal